삼성서울병원

Ko En

Hematology-Oncology Yoon, Sang Eun M.D

Expertise
Lymphoma, multiple myeloma, Transplantation, CAR-T cell therapy,Hematopoietic stem cell transplantation, Amyloidosis
Treament Schedule 05 月
DATE
WEB
01
THU
02
FRI
03
SAT
04
SUN
05
MON
06
TUE
07
WEB
08
THU
09
FRI
10
SAT
11
SUN
12
MON
13
TUE
14
WEB
15
THU
16
FRI
17
SAT
18
SUN
19
MON
20
TUE
21
WEB
22
THU
23
FRI
24
SAT
25
SUN
26
MON
27
TUE
28
WEB
29
THU
30
FRI
31
AM
PM
Treament Schedule 06 月
DATE
SAT
01
SUN
02
MON
03
TUE
04
WEB
05
THU
06
FRI
07
SAT
08
SUN
09
MON
10
TUE
11
WEB
12
THU
13
FRI
14
SAT
15
SUN
16
MON
17
TUE
18
WEB
19
THU
20
FRI
21
SAT
22
SUN
23
MON
24
TUE
25
WEB
26
THU
27
FRI
28
SAT
29
SUN
30
AM
PM

Medical Education

2016~2020 Ph.D. in Medicine Medical school, EWHA Womans University, Seoul, Korea
2008~2012 Master of Science Medical school, EWHA Womans University, Seoul, Korea

Post-Graduate Training

Fellowship   2018~2019 Hematology/Oncology, Samsung Medical Center, Seoul, Korea
2017~2018 Hematology/Oncology, EWHA Womans university hospital, Seoul, Korea
Residency   2013~2017 Hematology/Oncology, EWHA Womans university hospital, Seoul, Korea
Internship   2012~2013 Hematology/Oncology, EWHA Womans university hospital, Seoul, Korea

Professional Appointments

2019~2024 Clinical Instructor Hematology/Oncology, Samsung Medical Center, Seoul, Korea
2024~Present Assistant Professor Hematology/Oncology, Samsung Medical Center, Seoul, Korea

Professional Memberships

2017~Present Member The Korean society of hematology
2013~Present Member The Korean association of internal medicine.

Selected Publications

  • J NEUROIMMUNOL 2021 10.1016/j.jneuroim.2021.577564 Increased proportion of CD20+T cells after rituximab treatment in patient with neuromyelitis optica later diagnosed with lung B-cell lymphoma: A case report Lee1, JK; Kwon, S; Han, JH; Yoon, SE; Kim, BJ; Kang, ES
    View PubMed
  • KOREAN J INTERN MED 2021 10.3904/kjim.2019.367 Real-world data on the survival outcome of patients with newly diagnosed Waldenstrom macroglobulinemia Cho1, JH; Shim, JH; Yoon, SE; Kim, HJ; Kim, SH; Ko, YH; Lee, ST; Kim, K; Kim, WS; Kim, SJ
    View PubMed
  • CANCER MANAG RES 2021 10.2147/CMAR.S309092 Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma Lee1, YP; Hong, JY; Yoon, SE; Cho, J; Shim, JH; Bang, Y; Kim, WS; Kim, SJ
    View PubMed
  • EXP HEMATOL ONCOL 2021 10.1186/s40164-021-00224-3 Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas Yoon1, SE; Cho, J; Kim, YJ; Ko, YH; Park, WY; Kim, SJ; Kim, WS
    View PubMed
  • FRONT ONCOL 2021 10.3389/fonc.2021.628807 Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Lee1, B; Lee, H; Cho, J; Yoon, SE; Kim, SJ; Park, WY; Kim, WS; Ko, YH
    View PubMed